EL
Insider
Edward J Ludwig
DirectorEdward J Ludwig (Director) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in Boston Scientific Corporation (BSX). Across 2 priced purchase filings, the average 21-session return was -7.4% from execution and -10.2% from disclosure (delay-adjusted; derived). The largest single filing was $227K of BSX (5,000 sh × $45.48, as filed), executed Jul 31.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-7.4%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-10.2%
same 2 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$430K
shares × price, as filed
Last traded
Jul 31
Filed Aug 3
Median ADV $938.4M across their filed names
Open performance→Volume by month
Buys $430K
Sells $2.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
BSXRecent filings
BSXPURCHASE
Boston Scientific Corporation
View filing →
$227K5,000 sh × $45.48
Exec Jul 31
Filed Aug 3 · 4:29 PM ET BSXPURCHASE Boston Scientific Corporation View filing → $203K
3,580 sh × $56.68
Exec May 20
Filed May 21 · 5:21 PM ET BSXSALE Boston Scientific Corporation View filing → $424K
4,000 sh × $106.03
Exec Jul 25 2025
Filed Jul 28 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation View filing → $418K
4,000 sh × $104.59
Exec May 29 2025
Filed May 30 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation View filing → $1.3M
12,000 sh × $105.48
Exec Feb 11 2025
Filed Feb 12 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation View filing → $447K
4,877 sh × $91.63
Exec Nov 21 2024
Filed Nov 22 2024 · 5:30 PM ET